# A Prospective, Multi-Center Study of the Bard® Denali™ Retrievable Inferior Vena Cava Filter System

Study · id `cardio:ct-nct01305564` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01305564](<https://clinicaltrials.gov/study/NCT01305564>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01305564

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

## Technical summary

Registry record NCT01305564. Allocation not applicable; no masking; primary purpose treatment. Start 2011-06 (registry gives no type); primary completion 2015-06 (actual). Results posted on 2015-12-07.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 200 participants (enrolled count; ClinicalTrials.gov record NCT01305564, source copy `cardio:ctgov-nct01305564-2016-03-30`, retrieved 2026-10-31)
- Start date: 2011-06 (registry gives no type) (ClinicalTrials.gov record NCT01305564, source copy `cardio:ctgov-nct01305564-2016-03-30`, retrieved 2026-10-31)
- Primary completion: 2015-06 (actual) (ClinicalTrials.gov record NCT01305564, source copy `cardio:ctgov-nct01305564-2016-03-30`, retrieved 2026-10-31)
- Completion: 2015-07 (actual) (ClinicalTrials.gov record NCT01305564, source copy `cardio:ctgov-nct01305564-2016-03-30`, retrieved 2026-10-31)
- Results first posted: 2015-12-07 (ClinicalTrials.gov record NCT01305564, source copy `cardio:ctgov-nct01305564-2016-03-30`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT01305564, source copy `cardio:ctgov-nct01305564-2016-03-30`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01305564-2016-03-30`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Prospective, Multi-Center Study of the Bard® Denali™ Retrievable Inferior Vena Cava Filter System
- Condition: Pulmonary Embolism
- Intervention (Device): Denali inferior vena cava filter
- Lead sponsor: C. R. Bard
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Registry lists this organization as the lead sponsor: C. R. Bard (`cardio:org-c-r-bard`)

## Provenance

Content hash: 7980e8b5a0cd62bd63d60ca92df24f3de1bf47aeb758ef1a43de38db30fbd56e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
